APA (7th ed.) Citation

Balcells, M. E., Rojas, L., Le Corre, N., Martínez-Valdebenito, C., Ceballos, M. E., Ferrés, M., . . . Beltrán-Pavez, C. (2021). Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial. PLoS Medicine, 17(3), 1. https://doi.org/10.1371/journal.pmed.1003415

Chicago Style (17th ed.) Citation

Balcells, María Elvira, et al. "Early Versus Deferred Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial." PLoS Medicine 17, no. 3 (2021): 1. https://doi.org/10.1371/journal.pmed.1003415.

MLA (9th ed.) Citation

Balcells, María Elvira, et al. "Early Versus Deferred Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial." PLoS Medicine, vol. 17, no. 3, 2021, p. 1, https://doi.org/10.1371/journal.pmed.1003415.